Showing results (361-370 of 390) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL studyPhilip J Johnson, Shukui Qin, Joong-Won Park, et al.
Pigment Cell & Melanoma Research|October 7, 2023
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)Alexander Z Wei, Lanyi N Chen, Marlana Orloff, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Journal of the American Academy of Dermatology|February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapyNga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
JCO Precision Oncology|June 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy CandidatesUttam Satyal, Henkel Valentine, David Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial CancerJudit Börcsök, Zsofia Sztupinszki, Raie Bekele, et al.
Nature Medicine|December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaDavid Liu, Bastian Schilling, Derek Liu, et al.
Pageof 39